Michael WOODS

CEO, Nextmed Capital


NextMed Capital is an early stage life science VC firm and advises three medical device start or scale-up companies. Founded in 2016, its mission is to nurture the seeds of the next generation of medical innovation with the goal of becoming Australia's leading very early stage innovation and medical technology investor. NextMed Capital provides support to researchers seeking funds and expertise to accelerate commercialisation of technology. The company invests in projects as early as the pre-clinical phase and adds significant value to its investments through leveraging the combined commercial, entrepreneurial, project management, financing, business planning and academic skills of its experienced management team.


Brief Bio:

Michael brings a unique education and experience to the life science field. Following bachelor degrees in Genetics, Accounting and Finance, Michael joined Macquarie Group and spend 13 years as an investment banker, funds manager and project manager working in Melbourne, Seoul, Moscow, Almaty, and London. During this time, he invested more than $2 billion and ultimately established of a start-up company in Kazakhstan and executive roles in pre-revenue project in Philippines. After returning to Australia, Michael sought to apply his extensive strategic, commercial, financial and project management expertise to his passion for the life science sector where he has been advising as well as investing in early stage companies primarily focused on medical devices and artificial intelligence projects. Currently Michael holds a number of non-executive directorship roles, leads NextMed Capital.